AI Rewrites Drug Discovery: Eli Lilly and Twist Bioscience Chart Two Distinct Industrialization Paths Jun 19, 2026 Life Science, Technology
Why CRISPR Therapeutics Stock Is Stuck Despite Boasting the World’s First Approved CRISPR Therapy Jun 18, 2026 Life Science
RVMD’s Near-100% Year-To-Date Rally Sparks Valuation Debate: Has the Stock Gotten Too Pricy? Jun 5, 2026 Life Science
Strong Demand for GLP-1 Drugs Drives Eli Lilly’s Leadership with New Oral Medication and Acquisitions Jun 4, 2026 Life Science
Moderna Outshines Pharma Giants Lilly, Merck and Pfizer With 43% Year-to-Date Surge Jun 3, 2026 Life Science
Bristol-Myers Squibb’s Stock Looks Cheap on the Surface, but Hidden Risks Lurk Beneath Jun 2, 2026 Life Science
Is It Wise to Follow the Herd and Buy the Same Weight-Loss Drug Giant as the U.S. President? May 28, 2026 Life Science
Billionaires Reduce Holdings in UnitedHealth, Yet Wall Street Remains Bullish May 28, 2026 Life Science
Translating 10 Projects Weekly, Eli Lilly Launches Largest Acquisition Wave in Its History May 26, 2026 Life Science
Is Pfizer’s Stock, with a Dividend Yield Exceeding 6%, Undervalued by the Market? May 25, 2026 Life Science
